[1]
“Pharmacogenomic Profiling in Personalized Therapeutics: Predicting Drug Response in High-Risk Patients with Cardiometabolic Disorders”, Med. Int. J. Health Med. Res., vol. 1, no. 01, pp. 28–37, Oct. 2025, Accessed: Oct. 24, 2026. [Online]. Available: https://research-education.com/index.php/ijhmr/article/view/6